Pempidine

This classification denotes a nicotinic antagonist and antihypertensive agent with the molecular formula C10H21N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N5I18JI9D6, chemically known as 1,2,2,6,6-pentamethylpiperidine but generally known as pempidine, which bears US NIH Compound Identifier 6603. European Medicines Agency schedules Pempidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09658MIG. The term PEMPIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). PEMPIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pempidine under HS 29333999 and SITC 51574. As of Q4 2014, PEMPIDINE remains the US FDA Preferred Term for this commodity. Pempidine bears US NLM identifiers UMLS ID C0030810 and NCI Concept Code C66335. SMILES: CC1(CCCC(N1C)(C)C)C.